Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Ruby
Ruby
Ruby
Ruby
Ruby
Ruby
Ruby
Ruby
Ruby
Ruby
2024

Share:

Ruby

Upright photon radiotherapy treatment system

Ruby is a patient imaging, positioning, and treatment system enabling upright treatment of cancer using photon radiotherapy. The upright position empowers patients by allowing them to develop a greater connection with their clinicians and maintain a sense of independence and confidence throughout their treatment experience. Medically, there are tangible benefits to treating in an optimised upright position, and commercially, the product provides cost savings over traditional approaches and can be realised in existing and new facilities as well as a fully shielded standalone unit – making life saving treatments more affordable and accessible.

Client / Manufacturer

Leo Cancer Care Ltd

Horley, GB
Design

DCA Design International Limited

Warwick, GBMalcolm Boyd, Maartje Pel, RP Kruizinga, Marina Baranova, Daniel Jenkins, Josh Teodoro
Date of Launch
after 2024
Development Time
Confidential
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Trade / Industry

RELATED PROJECTS